Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002739119 | SCV003739793 | uncertain significance | Inborn genetic diseases | 2021-08-25 | criteria provided, single submitter | clinical testing | The c.1322A>G (p.Q441R) alteration is located in exon 10 (coding exon 10) of the CCM2 gene. This alteration results from a A to G substitution at nucleotide position 1322, causing the glutamine (Q) at amino acid position 441 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Baylor Genetics | RCV004560085 | SCV005049396 | uncertain significance | Cerebral cavernous malformation 2 | 2024-02-05 | criteria provided, single submitter | clinical testing |